Silent Partners

Features

How the brain’s less celebrated cells may drive Alzheimer’s disease and other dementias.

By Wynne Parry

Talkative neurons, those long-armed nerve cells that signal one another, get credit for much of what the brain accomplishes and blame when things go wrong. Increasingly, however, researchers are focusing on their counterparts — the cells that quietly protect the brain and ensure it functions properly. New recognition of their roles in cognitive disorders is leading to potential new treatment strategies.

Astrocytes

 

 Animation zooms in on neurons and astrocytes

 

Directors of Brain Health and Disease

Named for their stellar shape, astrocytes ensure neurons develop and work properly. For example, a single one can extend into hundreds of thousands of synapses, the communication hubs between neurons, regulating the transmission of signals that travel across these junctions.

“Neurons alone cannot function normally. There would be no brain without astrocytes,” says Dr. Anna Orr, an assistant professor of neuroscience and the Nan and Stephen Swid Assistant Professor of Frontotemporal Dementia Research, who became fascinated with astrocytes as a postdoctoral fellow.

Meanwhile, Dr. Adam Orr, her husband and an assistant professor of research in neuroscience, focuses on mitochondria, specialized parts within cells responsible for repackaging energy from food into a readily usable form, among other crucial tasks. “Just as astrocytes are integral to brain function, mitochondria are integral to cell function,” he says.

When Alarm Causes Harm

Under normal circumstances, mitochondria produce low amounts of highly reactive, oxygen-containing compounds, such as superoxide (O2-) and hydrogen peroxide (H2O2). However, they generate more of these compounds in the presence of tau tangles, inflammatory signals from microglia, and other changes that occur in Alzheimer’s disease and frontotemporal dementia. This increase sets off an internal alarm within the astrocytes, causing these cells to behave differently and disrupt neuronal function, according to Dr. Anna Orr.

The Orrs’ work suggests that the alarmed astrocytes can aggravate disease, including by worsening some of the very factors that instigated their transformation, such as tau tangles and brain inflammation.

Breaking the Cycle

Not only are these reactive compounds byproducts of normal processes, evidence also suggests that, at regular levels, they are required for healthy cell function. So, eliminating them entirely may not be the best option. Instead, the Orrs are developing precise modulators that block the excess production at its source, within particular sites in mitochondria, without interfering with these organelles’ ability to supply energy and carry out other functions.

Microglia

 

Animation zooms into neurons and microglia with tau. Zooming further in shows pieces of tau breaking off

 

Protectors and Clean Up Crew

Immune cells unique to the brain, microglia keep the brain safe and in working order by consuming and digesting any potential threat, whether a pathogen or piece of debris. Evidence suggests that these cells also contribute to cognitive decline.

“A lot of genetic mutations that affect microglia also lead to a higher risk of frontotemporal dementia and Alzheimer’s disease” says Dr. Li Gan, director of the Helen and Robert Appel Alzheimer’s Disease Research Institute, professor of neuroscience, and the Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases. “We want to find out why.”

This quest has led her to tau, a versatile, fiber-like protein found within cells, most notably in neurons. In dementia, tau misbehaves, forming tangles. As these tangles spread through the brain, patients’ conditions deteriorate. Dr. Gan’s research suggests that the microglia may inadvertently propel this progression.

Defensive Eating Goes Awry

When microglia encounter tau tangles floating about in the space between cells, the tangles activate an immunological switch within them. This pathway, known as NF-kB, tells the microglia it’s time to eat. These cells then rearrange their boundaries to surround and consume the tau tangles.

However, in doing so, microglia appear to cause more harm than good, Dr. Gan and her colleagues have found. Rather than fully breaking down their targets, microglia spit out toxic bits of tau. Other brain cells pick up these pieces, which seed new tangles. When ejected by the cells, these new tangles only further activate the microglia. Thus, a vicious cycle develops, fueling the tau tangles’ spread through the brain.

Narrowing the Target

By shutting down NF-kB, Dr. Gan’s team interfered with the spread of tau tangles in mice. However, this isn’t a realistic strategy for therapies because, without NF-kB, microglia become paralyzed and cannot defend the brain. What’s more, the loss of this pathway could also potentially impair the immune system in the rest of the body.

Subsequent research, however, has led to a more promising route: a branch of the NF-kB pathway activated by an enzyme called cGAS. Under normal circumstances, it responds only to viral infections. In dementia, however, it picks up on cellular damage caused by tau tangles. In experiments, researchers found that shutting off cGAS in microglia had a protective effect on neurons and could restore memory in mice.

In terms of potential therapies, “NF-kB is a sledgehammer, cGAS is a scalpel,” Dr. Gan says.

Illustrations: Yukai Du

Fall 2023 Front to Back

  • From the Dean

    Message from the Dean

    New Dean Robert A. Harrington, M.D. reflects on Weill Cornell Medicine’s tripartite mission — to care, to discover and teach — and ways to deepen and advance these goals.
  • Features

    Cancer Vaccines’ Promise

    Patients are closer than ever to benefiting from a new treatment approach, thanks to strides in immunotherapy and COVID-19 vaccine technology.
  • Features

    Silent Partners

    How the brain’s less celebrated cells may drive Alzheimer’s disease and other dementias.
  • Features

    Future Forward

    Dean Robert A. Harrington, M.D., shares his vision for Weill Cornell Medicine in a wide-ranging Q&A.
  • Notable

    A New Residence for Graduate and Medical Students

    A modern new residence on the Upper East Side campus will enhance the student experience.
  • Notable

    Dateline

    Dr. Jyoti Mathad’s research could transform maternal health in under-resourced countries.
  • Notable

    Overheard

    Weill Cornell Medicine faculty members are leading the conversation about important health issues across the country and around the world.
  • Notable

    News Briefs

    Notable faculty appointments, honors, awards and more — from around campus and beyond.
  • Grand Rounds

    Playing With Heart

    A transplant serves up a new beginning.
  • Grand Rounds

    An End to Suffering in Silence

    Weill Cornell Medicine’s Center for Female Pelvic Health is committed to treating women with dignity.
  • Grand Rounds

    News Briefs

    The latest on teaching, learning and patient-centered care.
  • Grand Rounds

    3 Questions

    During the COVID-19 pandemic, Weill Cornell Medicine adapted medical education. It wasn’t the first time the institution responded to historic public health events.
  • Discovery

    Making a Male “Pill”

    A new “on-demand” method in development could offer men another choice for contraception.
  • Discovery

    Scientists Target Human Stomach Cells for Diabetes Therapy

    Stem cells from the human stomach offer a promising approach to treating diabetes.
  • Discovery

    Findings

    The latest advances in faculty research, published in the world’s leading journals.
  • Discovery

    3 Questions

    Dr. Gunisha Kaur and the team at the Weill Cornell Medicine Human Rights Impact Lab are finding ways to improve refugee health.
  • Alumni

    Profiles

    From serving vulnerable communities to forging critical connections to move research from the bench to the bedside, our alumni are making an impact.
  • Alumni

    Notes

    What’s new with you? Keep your classmates up to date on all your latest achievements with an Alumni Note.
  • Alumni

    In Memoriam

    Marking the passing of our faculty and alumni.
  • Alumni

    Moments

    Marking celebratory events in the lives of our students, including the White Coat Ceremony and receptions for new students.
  • Second Opinion

    AI in RX

    How can chatbots be used in medicine?
  • Exchange

    Diversifying Medicine

    Two physicians discuss the unique experiences of Latino men in medicine and the crucial need for diversity.
  • Muse

    Writing to Make Meaning

    Dr. Rachel Kowalsky is a pediatric emergency physician and an award-winning author.
  • Spotlight

    At the Forefront of Immunometabolism

    Dr. Ke “Dave” Xu (Ph.D. ’21) and Dr. Anjin Xianyu (Ph.D. ’20), the founders of META Pharmaceuticals, are developing treatments for autoimmune diseases.